Chemotherapy-induced peripheral neuropathy (CIPN) can be a challenging side effect of cancer treatment. This webinar, sponsored by Lilly, will provide an overview of CIPN, including what causes it, who may be at greater risk, why it develops, and the symptoms to look out for.
The second half of the webinar will focus on managing CIPN, including treatment options, strategies that may help prevent or reduce symptoms, and what patients can expect over time.
The webinar will end with a live Q&A. Please submit your questions at registration.
About the speaker
Dr. Noah Kolb, MD is a neuromuscular neurologist and Professor of Neurological Science at the University of Vermont. He specializes in the treatment of neuromuscular diseases such as neuropathy, myasthenia gravis, ALS, myopathy and myositis, and muscular dystrophy. His research is primarily interested in understanding, treating, and preventing chemotherapy-induced neuropathy, which is a side effect of some commonly used cancer treatments.
